CPL207-280CA

N/A

Report date: 2026/05/05 20:00:16
NME

Base Information

Drug NameCPL207-280CA
Drug Alias NameCPL-207280CPL-207-280CPL207-280CACPL207280-51CPL'280
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 1 agonists
TargetsFree fatty acid receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma Sa
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes MellitusDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A